FDA Approves US Merck-Pfizer Cancer Treatment

04:25 EDT 30 Apr 2019 | CHEManager

Two months earlier than expected, the US Food and Drug Administration (FDA)  has greenlighted the use of Merck & Co’s multi-indication cancer treatment Keytruda in combination with Pfizer’s Inlyta as a treatment for previously untreated advanced renal cell carcinoma.

Original Article: FDA Approves US Merck-Pfizer Cancer Treatment


More From BioPortfolio on "FDA Approves US Merck-Pfizer Cancer Treatment"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...